身体活動による良性前立腺増殖の調節 - ミオキンの新興する役割:物語のレビュー

Saad Alshahrani¹

¹Department of Surgery, Division of Urology, College of Medicine, Prince Sattam bin Abdulaziz University, Alkharj 11942, Saudi Arabia.

Medicina (Kaunas, Lithuania)

|August 28, 2025

まとめ

定期的な運動は,ホルモン,炎症,およびミオカインに影響を与えることで,良性前立腺増殖 (BPH) のリスクと重症度を減らすことができます. 運動は様々な生物学的経路を通して前立腺の健康に有益です

科学分野:

泌尿器科
運動生理学
分子生物学

背景:

良性前立腺増殖 (BPH) は高齢の男性に多く見られ,下部泌尿器系症状 (LUTS) と生活の質の低下を引き起こします.
ホルモンの調節不全と慢性炎症は BPH の既知の要因ですが,身体活動の役割はますます認識されています.

研究の目的:

運動がBPHのリスクと症状の重さに及ぼす影響に関する証拠をまとめます.
運動によって前立腺の健康を守る可能性があるミオキンの役割を含む潜在的メカニズムを探る

主な方法:

運動とBPHの関係を調べる定量的な研究の記述的レビュー
ホルモンプロファイル,炎症,酸化ストレス,オートファギー,およびミオキンの信号伝達を含む生物学的経路の探索.

主要な成果:

定期的な運動は,BPHの発生率と進行の減少と関連しています.
運動は共感神経系,ホルモン (テストステロン,インスリン),炎症,酸化ストレスを調節することで前立腺を保護する.
運動中に分泌されるミオカイン (イリシン,IL-6,BDNF,ミオスタチン) は,BPHに関連する炎症および代謝過程を調節する役割を果たします.

結論:

身体活動はBPHの管理のための非薬学的介入として有望です.
ミオキンは,前立腺の健康とBPHの治療の可能性への直接的な影響を理解するために,将来の研究にとって重要な分野です.

キーワード:

良性前立腺増殖運動する炎症ミオキネス前立腺の健康

さらに関連する動画

13:18

How to Study Basement Membrane Stiffness as a Biophysical Trigger in Prostate Cancer and Other Age-related Pathologies or Metabolic Diseases

Published on: September 20, 2016

9.8K

10:26

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology

Published on: August 18, 2014

26.4K

関連する概念動画

01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

01:20

Disorders of the Male Reproductive System

570

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....

570

01:28

Nitric Oxide Signaling Pathway

5.2K

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...

5.2K

01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...

01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

958

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...

958

01:18

Hypertension and Regulation of Blood Pressure

3.1K

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...